Cash Equivalents - Myomo Inc (F:0M61) - Alpha Spread
Have any thoughts about
Myomo Inc?
Write Note

Myomo Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Myomo Inc
Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Myomo Inc
F:0M61
Cash Equivalents
$6.9m
CAGR 3-Years
-21%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$4.5B
CAGR 3-Years
12%
CAGR 5-Years
54%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.9B
CAGR 3-Years
3%
CAGR 5-Years
88%
CAGR 10-Years
23%
Stryker Corp
NYSE:SYK
Cash Equivalents
$1.9B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
4%
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7B
CAGR 3-Years
-7%
CAGR 5-Years
17%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$2.6B
CAGR 3-Years
42%
CAGR 5-Years
37%
CAGR 10-Years
18%

See Also

What is Myomo Inc's Cash Equivalents?
Cash Equivalents
6.9m USD

Based on the financial report for Jun 30, 2024, Myomo Inc's Cash Equivalents amounts to 6.9m USD.

What is Myomo Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
1%

Over the last year, the Cash Equivalents growth was 74%. The average annual Cash Equivalents growth rates for Myomo Inc have been -21% over the past three years , 1% over the past five years .

Back to Top